NEW FUNDING: Why We Invested in Qure4U  Read More

NEWS: Medly Pharmacy Announces Agreement to Acquire Pharmaca: Medly Pharmacy Announces Agreement to Acquire Pharmaca Expanding Free Same-Day Delivery to Include Health and Wellness Products  Read More

NEW FUNDING: Why We Invested in US Mobile  Read More

ASK JENNY ANYTHING: Volition Venture Partner Jenny Fleiss answers your questions: What Should I Expect During Investor Diligence?  Read More

SCALING SUCCESS PODCAST: Sean Cantwell interviews Paul Melchiorre for Scaling Success  Read More

Categories:
Categories:
Categories:
Categories:
Portfolio News

iPipeline Named a Distribution Leading Vendor in Life/Health Category of 2014 Celent Report

JustinWood
Volition

iPipeline Shows Strong Performance in the Life/Health Metacategory for North America

iPipeline®, the leader in on-demand marketing, selling and processing solutions for the nation’s top insurance carriers, distributors, financial institutions, and their agents and advisors, today announced it led the Life/Health Metacategory for Distribution in Celent’s 2014 Insurance Software Deal Trend Report with 52% of the Deal Volume. iPipeline also ranked 8th among the 51 vendors in the 2014 “Traction Index,” which Celent determined by a weighted score measuring the volume and type of agreements software companies secured for the performance period. iPipeline led in the Life/Health Distribution Metacategory in Celent’s 2009, 2010, 2011, 2012 and 2013 Insurance Software Deal Trend Reports.

“2013 was a landmark year for iPipeline, and I attribute this to our ability to meet the needs of specific customers that other software vendors cannot. To better support their business development needs, we executed the strategic acquisitions of Aplifi and XRAE, and these enabled us to create the most versatile and productive platform for the life insurance, annuities and healthcare industry,” said Tim Wallace, CEO, iPipeline. “Our investments in R&D and focus on the success of our customers are delivering increasing returns across the industry, and we continue to deliver on our promise to dramatically improve how insurance is sold through our commitment to innovation and process improvement.”

“This is the sixth year in which we have received this validation from Celent’s research team, and it speaks volumes to the applicability of our solutions within the life, annuities, and healthcare industry,” added Wallace. “Our focus remains intensely on globally delivering comprehensive, high-value solutions, and we are pleased to have a commanding percentage of the software deal volume in the life/health category.”

“Distribution deals continue to be strong in life insurance,” says Karen Monks, analyst with Celent’s Insurance group and coauthor of the report. “Our conversations with life insurers reveal that many are focusing on improving the sales and distribution process through automation; the deal data supports this trend. This trend bodes well for iPipeline.” 

Similar Articles